Targeted mRNA Therapeutics for Treatment of Kidney Diseases
Time: 4:30 pm
day: Day One PM
Details:
- Mercurna’s technology platform combines unique cell-targeting moieties, with a lipid-based delivery vehicle to deliver engineered mRNA with high specificity
- Active targeting strategies through optimised technology on targeted LNPs
- Showcasing examples on how Mercurna leverages its platform for development of targeted mRNA therapeutics to treat kidney diseases
